Review highlights potential uses of snakin antimicrobial peptides against resistant pathogens in various industries.
Antibiotic resistance has become a significant challenge for global health. Exploring novel antimicrobial compounds as alternatives to antibiotics is increasingly prominent in combating resistant pathogens. Antimicrobial peptides (AMPs), produced by various organisms, are considered natural antibiotic candidates that can be used against multidrug-resistant microorganisms. The snakin family of plant-based AMPs is a promising candidate for use in the agriculture, food and pharmaceutical industries due to its antimicrobial activity against both phytopathogenic and clinical species. This review summarizes current AMP databases and the snakin family of plant AMPs deposited in the Universal Protein Resource, UniProt. It also provides knowledge about potential uses of this family in biotechnology.
No takes yet. Share an insight, caveat, or question.
Teker et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: